Ipsen Group
| Ipsen Group
|
|
|---|---|
 |
|
| legal form | AG |
| ISIN | FR0010259150 |
| founding | 1929 |
| Seat | Paris , France |
| Branch | pharmacy |
| Website | www.ipsen.com |
Ipsen Group is a French company with headquarters in Paris and Germany in Ettlingen . The company is owned by the Beaufour family . The pharmaceutical company employs around 4,000 people. The company was founded in 1929.
The drugs manufactured by Ipsen Group include the
- Oncology - Decapeptyl ®
- Endocrinology - Somatuline ® , NutropinAq ® , Testim ®
- neuromuscular disorders - Dysport ® .
Foundation and Awards
The Ipsen Foundation (Fondation Ipsen) awards various science prizes .
- Since 1990 the Neuronal Plasticity Prize endowed with 60,000 euros .
- Since 1992 the Jean Louis Signoret Prize for Neuropsychology, endowed with 20,000 euros .
- Since 1996 the Longevity Prize endowed with 20,000 euros .
- Since 2002 the Endocrine Regulation Prize endowed with 20,000 euros .
Web links
- Ipsen (ipsen.com, English)
- Fondation Ipsen (ipsen.com, English)
Individual evidence
- ↑ Home - Germany. Retrieved on March 27, 2018 (German).